Calidi Biotherapeutics and Edoc Acquisition Corp. Agree to
-Total gross proceeds from transaction expected to be approximately $117 million prior to redemptions, combining $25 million PIPE and up to $92 million...
Source: globenewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Edoc Class. Real-time updates on events, politics, business and more.